Author

J. B. Lee

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Bioengineering· 1 Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Mortha· 1 shared A. S. Carreira· 1 shared B. Das· 1 shared C. Alexander· 1 shared C. Cai· 1 shared C. Gonzalez-Garcia· 1 shared D. Dhananjaya· 1 shared D. H. Kim· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Mortha

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Cell therapy with IL-10-producing group 2 innate lymphoid cells suppresses Graft-versus-Host disease

K. T. Reid, S. J. Colpitts, J. A. Mathews, A. S. Carreira, J. M. Murphy, D. T. Borovsky, W. Cui, T. A. Moya, N. Sachewsky, J. An, Y. Xia, A. Mortha, J. B. Lee, L. Zhang, I. Novitzky-Basso, , S. Q. Crome

This study demonstrates that IL-10-producing group 2 innate lymphoid cells (ILC210) can suppress Graft-versus-Host Disease (GVHD) in a humanized model without compromising graft-versus-leukemic effects.

bioRxiv · Aug 21, 2023Immunology

Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders

S. A. Raithatha, J. M. Hagel, K. Matinkhoo, L. Yu, D. Press, S. G. Cook, G. Sharma, D. Dhananjaya, G. Jensen, J. B. Lee, C. Cai, J. Gallant, J. S. Bains, J. E. Tucker, P. J. Facchini

This paper identifies novel psilocin prodrugs with altered pharmacokinetics and reduced psychedelic effects, maintaining therapeutic benefits for anxiety disorders.

bioRxiv · May 16, 2023Pharmacology & Toxicology

Moderate-intensity exercise might be a competitive protocol to prevent obesity and obesity-related metabolic diseases

R.-W. Kwon, S.-J. Lee, T.-W. Kim, J. B. Lee

This study compares moderate- and high-intensity exercise effects on cytokines and neurotransmitters in healthy men, finding moderate-intensity exercise may be more effective for obesity prevention.

bioRxiv · Nov 18, 2021 · PreprintPhysiology

The Effect of a Fennel Extract on the STAT Signaling and Intestinal Barrier Function

J. Rabalais, P. Kozan, T. Lu, N. Durali, K. Okamoto, B. Das, M. D. McGeough, J. B. Lee, K. E. Barrett, R. Marchelletta, M. Sivagnanam

This study shows that fennel extract improves intestinal barrier function and reduces STAT pathway activation in both in vitro and in vivo models of inflammation.

bioRxiv · Jul 1, 2021 · PreprintPharmacology & Toxicology

Designing Topographically Textured Microparticles For Induction and Modulation of Osteogenesis in Mesenchymal Stem Cell Engineering

M. H. Amer, M. Alvarez-Paino, J. McLaren, F. Pappalardo, S. Trujillo, J. Q. Wong, S. Shrestha, S. Abdelrazig, J. B. Lee, L. Stevens, D. H. Kim, C. Gonzalez-Garcia, D. Needham, M. Salmeron-Sanchez, K. M. Shakesheff, , F. R. Rose

This study shows that topographically textured microparticles can enhance osteogenic markers in mesenchymal stem cells without exogenous factors.

bioRxiv · Mar 22, 2020Bioengineering